Results 81 to 90 of about 66,200 (293)

Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well‐Tolerated in a Pivotal Phase III Trial

Allergy, EarlyView.
A pivotal Phase III DBPC adaptive trial was conducted with PQ Grass 27600 SU. The primary endpoint EAACI‐CSMS0–6 demonstrated a highly significant, clinically meaningful improvement for PQ Grass of −0.27 points (95% CI: −0.42 to −0.12), corresponding to a relative difference of −20.3% (p = 0.0005) over placebo. Highly consistent secondary endpoints and
Stefan Zielen, Jonathan A. Bernstein, Gunter J. Sturm, Marek Jutel, Oliver Pfaar, the RESONATE Investigator Group, R. Gattringer, K. Gangl, J. Potesil, T. Sykora, M. Mattauchova, P. Panzner, M. Kasl, Z. Chovancova, T. Hofstetr, J. Poloniova, A. Zlamal, J. Haas, F. Heimlich, C. Korte, S. Ballenberger, J. Grosskopf, P. Heymer, C. Bergmann, M. Froer, G. Hoheisel, U. Thieme, C. Grigat, U. Schaefer, P. El Naib, A. Schwinn, S. Runge, M. Worm, S. Pauser, M. Jandl, J.‐C. Bohn, C. von Engelhardt, A. Schaefer, J. Rieker‐Schwienbacher, M. Cuevas, S. Lassmann, Y. Yarin, T. Nyeky, I. Szanyi, V. Urban, J. Nemes, P. Borowy, Z. Siergiejko, E. Janusik, B. Tluczykont, D. Madra‐Rogacka, S. Ptaczek, I. Wojciechowska, J. Orlicz‐Widawska, M. Żurowska‐Gębala, T. Hofman, S. Tokarski, M. Bederska, A. Latos, K. Kowal, E. Markut‐Miotla, E. Pisarczyk‐Bogacka, P. Kuna, B. Majorek‐Olechowska, A. Chmielewska, B. Kucinska, C. Chwala, P. Parikh, J. Sublett, J. Weiss, J. Leflein, P. Shapero, D. McNeil, K. O’Brien, E. Sher, G. Steven, L. Ford, A. Darter, L. Clore, D. Elkayam, G. Myers, J. Matz, M. Vanderwalker, S. Smiley, J. DeAngelo, A. Montanaro, J. Delgado, W. Greisner, C. Thornblade, M. Moss, Mohamed H. Shamji, Ralph Mösges, Markus Berger, Uwe E. Berger, Lawrence DuBuske, Janice A. Layhadi, Ludger Klimek, Markus Ollert, Murray A. Skinner, Matthias F. Kramer, Pieter‐Jan de Kam   +100 more
wiley   +1 more source

POSSIBILITIES OF USE OF THE MODERN ANTIHISTAMINE MEDICINES IN THERAPY OF PATIENTS WITH ALLERGIC RHINITIS

Медицинский совет, 2017
Allergic rhinitis as one of the most common non-infectious respiratory inflammatory diseases is a global public health problem. The course of allergic rhinitis, its effect on the pathology of other organs and systems, the likelihood of complications and ...
G. N. Nikiforova, V. M. Svistushkin, A. N. Slavsky, D. M. Pshonkina   +3 more
doaj   +3 more sources

Pollen respiratory allergy: Is it really seasonal?

World Allergy Organization Journal, 2023
Allergic rhinitis (AR) is a highly prevalent respiratory condition that carries a heavy burden and can have a significant impact on patient quality of life.
Gennaro D'Amato, MD, Margarita Murrieta-Aguttes, MD, Maria D'Amato, MD, Ignacio Javier Ansotegui, MD, PhD   +3 more
doaj  

Work-related allergic rhinitis: a contemporary review of the literature [PDF]

, 2017
Adverse health effects have been reported in workers exposed to inhaled allergens. Allergic rhinitis is a heterogeneous disorder that significantly affects daily activity, work productivity, sleep, learning, and quality of life in all generations ...
BALLA, MARIA PAOLA, Marsico, Cataldo, Marsico, Salvatore, MASSONI, FRANCESCO, RALLI, MASSIMO, RICCI, LIDIA, RICCI, PASQUALE, RICCI, Serafino   +7 more
core   +1 more source

Clinical Benefits of a Randomized Allergy App Intervention in Grass Pollen Sufferers: A Controlled Trial

Allergy, EarlyView.
Different functions of an allergy app were tested for clinical benefit in a randomized, controlled trial in patients with grass pollen allergy. Participants with pollen forecast function took more medication and had fewer symptoms than participants without pollen forecast. A symptom forecast was developed based on the study data.
Caroline Holzmann, Johannes Karg, Matthias Reiger, Rajiv Kharbal, Paola Romano, Sabrina Scheiwein, Claudia Khalfi, Anna Muzalyova, Jens O. Brunner, Gertrud Hammel, Athanasios Damialis, Claudia Traidl‐Hoffmann, María P. Plaza, Stefanie Gilles   +13 more
wiley   +1 more source

Rhinitis in general practice [PDF]

, 2007
A 3 year old boy presented with a 3 week history of nasal obstruction, clear rhinorrhea, difficulty with feeding and a productive cough. Child was afebrile, had occasional watery itchy eyes and mother claimed that at night he tended to wake up a couple ...
drkvassallo@yahoo.co.uk, Vassallo, Kenneth   +1 more
core  

Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series [PDF]

, 2000
OBJECTIVE: To test the hypothesis that homoeopathy is a placebo by examining its effect in patients with allergic rhinitis and so contest the evidence from three previous trials in this series.
Aitchison, T,, Llewellyn-Jones, R.H., McSharry, C., Reilly, D., Taylor, M.A.   +4 more
core   +2 more sources

SCIT With Hypoallergenic Bet v 1 Compared to Conventional Extract: Poorer Blocking Antibody Capacity Dominated by IgG1 Instead of IgG4

Allergy, EarlyView.
A 6‐month randomized, double‐blind, placebo‐controlled first‐in‐human clinical trial was conducted in birch pollen allergic patients comparing the Bet v 1‐fold‐variant BM41 with a licensed birch pollen extract‐based treatment, as active comparator, and placebo.
Lorenz Aglas, Line Kring Tannert, Serge A. Versteeg, Scott A. Smith, Ewa A. Bartko, Mario Wenger, Amin Kraiem, Hannah Widauer, Natália Nunes, Sibile Sinkunaite, Frank Stolz, Laurian Jongejan, Angela Neubauer, Lars H. Blom, Fatima Ferreira, Lars K. Poulsen, Carsten Bindslev‐Jensen, Ronald van Ree   +17 more
wiley   +1 more source

Effect of the Multi‐Strain Probiotic SYN‐53 in the Management of Allergic Rhinoconjunctivitis

Allergy, EarlyView.
Allergic rhinoconjunctivitis has previously been linked to gut dysbiosis. A double‐blind, placebo‐controlled, randomized clinical trial with the multi‐strain probiotic food supplement SYN‐53 was conducted. Eighty‐four subjects affected by allergic rhinoconjunctivitis were exposed to grass pollen in an allergen exposure chamber to assess safety and ...
Karl‐Christian Bergmann, Torsten Zuberbier   +1 more
wiley   +1 more source

Effects of topical capsaicin in seasonal allergic rhinitis. [PDF]

Thorax, 1995
Mucosal exudation (luminal entry) of bulk plasma is a key feature of airway defence and inflammation. In guinea pig and rat airways this response is readily produced by neurogenic irritants, notably capsaicin. Thus "neurogenic airway inflammation" has become an established concept.
Magnus Andersson, Camilla I. Svensson, C. G. A. Persson, Lennart Greiff   +3 more
openaire   +3 more sources